96 related articles for article (PubMed ID: 23434429)
1. TCTP/HRF pathway and angiogenesis: a feasible intercourse in chronic lymphocytic leukemia.
Yağcı M; Yegin ZA; Akyürek N; Kayhan H; Ozkurt ZN; Sucak GT; Haznedar R
Leuk Res; 2013 Jun; 37(6):665-70. PubMed ID: 23434429
[TBL] [Abstract][Full Text] [Related]
2. History of Histamine-Releasing Factor (HRF)/Translationally Controlled Tumor Protein (TCTP) Including a Potential Therapeutic Target in Asthma and Allergy.
MacDonald SM
Results Probl Cell Differ; 2017; 64():291-308. PubMed ID: 29149416
[TBL] [Abstract][Full Text] [Related]
3. Choice of endothelial marker is crucial for assessment of bone marrow microvessel density in chronic lymphocytic leukemia.
Smolej L; Kasparová P
APMIS; 2008 Dec; 116(12):1058-62. PubMed ID: 19133008
[TBL] [Abstract][Full Text] [Related]
4. Distinct characteristics of signal transduction events by histamine-releasing factor/translationally controlled tumor protein (HRF/TCTP)-induced priming and activation of human basophils.
Vonakis BM; Macglashan DW; Vilariño N; Langdon JM; Scott RS; MacDonald SM
Blood; 2008 Feb; 111(4):1789-96. PubMed ID: 18042794
[TBL] [Abstract][Full Text] [Related]
5. A proliferation-inducing ligand (APRIL) serum levels predict time to first treatment in patients affected by B-cell chronic lymphocytic leukemia.
Tecchio C; Nichele I; Mosna F; Zampieri F; Leso A; Al-Khaffaf A; Veneri D; Andreini A; Pizzolo G; Ambrosetti A
Eur J Haematol; 2011 Sep; 87(3):228-34. PubMed ID: 21595749
[TBL] [Abstract][Full Text] [Related]
6. Modern prognostic factors and angiogenesis in chronic lymphocytic leukemia: more data needed.
Smolej L; Andrys C; Vroblova V
Leuk Res; 2007 Dec; 31(12):1763-4. PubMed ID: 17617454
[TBL] [Abstract][Full Text] [Related]
7. Prognostic importance of soluble CD23 in B-cell chronic lymphocytic leukemia.
Saka B; Aktan M; Sami U; Oner D; Sanem O; Dinçol G
Clin Lab Haematol; 2006 Feb; 28(1):30-5. PubMed ID: 16430457
[TBL] [Abstract][Full Text] [Related]
8. [Angiogenesis in the bone marrow of patients with chronic lymphocytic leukaemia].
Kasparová P; Smolej L
Cesk Patol; 2007 Apr; 43(2):50-8. PubMed ID: 17623976
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of circulating endothelial cells as noninvasive marker of angiogenesis in patients with chronic lymphocytic leukemia.
Gora-Tybor J; Jamroziak K; Szmigielska-Kaplon A; Krawczynska A; Lech-Maranda E; Wierzbowska A; Jesionek-Kupnicka D; Blonski JZ; Robak T
Leuk Lymphoma; 2009 Jan; 50(1):62-7. PubMed ID: 19125384
[TBL] [Abstract][Full Text] [Related]
10. Serum insulin-like growth factor is not elevated in patients with early B-cell chronic lymphocytic leukemia but is still a prognostic factor for disease progression.
Molica S; Vitelli G; Mirabelli R; Digiesu G; Giannarelli D; Cuneo A; Ribatti D; Vacca A
Eur J Haematol; 2006 Jan; 76(1):51-7. PubMed ID: 16343271
[TBL] [Abstract][Full Text] [Related]
11. Carbonyl group serum levels are associated with CD38 expression in patients with B chronic lymphocytic leukemia.
Musolino C; Allegra A; Alonci A; Saija A; Russo S; Cannavò A; Cristani M; Centorrino R; Saitta S; Alibrandi A; Gangemi S
Clin Biochem; 2011 Dec; 44(17-18):1487-90. PubMed ID: 21945028
[TBL] [Abstract][Full Text] [Related]
12. Identifying the stage of new CLL patients using TK, ZAP-70, CD38 levels.
Rivkina A; Vitols G; Murovska M; Lejniece S
Exp Oncol; 2011 Jun; 33(2):99-103. PubMed ID: 21716207
[TBL] [Abstract][Full Text] [Related]
13. Overexpressed BAG3 is a potential therapeutic target in chronic lymphocytic leukemia.
Zhu H; Wu W; Fu Y; Shen W; Miao K; Hong M; Xu W; Young KH; Liu P; Li J
Ann Hematol; 2014 Mar; 93(3):425-35. PubMed ID: 23978946
[TBL] [Abstract][Full Text] [Related]
14. Increased angiogenesis induced by chronic lymphocytic leukemia B cells is mediated by leukemia-derived Ang2 and VEGF.
Maffei R; Martinelli S; Castelli I; Santachiara R; Zucchini P; Fontana M; Fiorcari S; Bonacorsi G; Ilariucci F; Torelli G; Marasca R
Leuk Res; 2010 Mar; 34(3):312-21. PubMed ID: 19616847
[TBL] [Abstract][Full Text] [Related]
15. Potential role of histamine releasing factor (HRF) as a therapeutic target for treating asthma and allergy.
Macdonald SM
J Asthma Allergy; 2012; 5():51-9. PubMed ID: 23055753
[TBL] [Abstract][Full Text] [Related]
16. Comparison of bone marrow and peripheral blood ZAP-70 status examined by flow cytometric immunophenotyping in patients with chronic lymphocytic leukemia.
Sheridan R; Mounajjed T; Ehrmann DE; Hurtubise PE; Schrager JA
Cytometry B Clin Cytom; 2006 Jul; 70(4):320-1. PubMed ID: 16906578
[TBL] [Abstract][Full Text] [Related]
17. DNA-dependent protein kinase is a therapeutic target and an indicator of poor prognosis in B-cell chronic lymphocytic leukemia.
Willmore E; Elliott SL; Mainou-Fowler T; Summerfield GP; Jackson GH; O'Neill F; Lowe C; Carter A; Harris R; Pettitt AR; Cano-Soumillac C; Griffin RJ; Cowell IG; Austin CA; Durkacz BW
Clin Cancer Res; 2008 Jun; 14(12):3984-92. PubMed ID: 18559621
[TBL] [Abstract][Full Text] [Related]
18. Expression of the chemokine receptors CXCR4 and CCR7 and disease progression in B-cell chronic lymphocytic leukemia/ small lymphocytic lymphoma.
Ghobrial IM; Bone ND; Stenson MJ; Novak A; Hedin KE; Kay NE; Ansell SM
Mayo Clin Proc; 2004 Mar; 79(3):318-25. PubMed ID: 15008605
[TBL] [Abstract][Full Text] [Related]
19. Role of angiogenesis in chronic lymphocytic leukemia.
Letilovic T; Vrhovac R; Verstovsek S; Jaksic B; Ferrajoli A
Cancer; 2006 Sep; 107(5):925-34. PubMed ID: 16832815
[TBL] [Abstract][Full Text] [Related]
20. High expression of hematopoietic cell specific Lyn substrate-1 (HS1) predicts poor survival of B-cell chronic lymphocytic leukemia patients.
Butrym A; Majewski M; Dzietczenia J; Kuliczkowski K; Mazur G
Leuk Res; 2012 Jul; 36(7):876-80. PubMed ID: 22333038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
